Researchers compared whether the prevalence of vitamin D insufficiency at 40 weeks and at 3 months corrected age group differed between the groups. They also looked at whether infants with higher supplement D levels also had more powerful bones at three months corrected age and whether supplementation resulted in vitamin D levels which were too high. Results demonstrated that VDI was common in both organizations before they received supplements . After supplementation, the prevalence of VDI at 40 weeks was 43 % reduced the 800 IU group compared to the 400 IU group . Furthermore, VDI was significantly low in the 800 IU group when the infants were 3 months aged . Related StoriesBIDMC scientists discover new supplement B3 pathway that regulates liver metabolismResearchers find that supplement D may play significant part in avoiding AMD among womenStudy shows vitamin D, calcium supplements fail to drive back colorectal cancer Four infants would have to be supplemented with 800 IU daily to reduce one case of supplement D insufficiency, said lead author Chandra Kumar Natarajan, DM.Efficacy Analyses The principal efficacy end point was sustained virologic response at 24 weeks after the end of treatment. Analyses had been performed on the modified intention-to-treat population, including patients who got undergone randomization and received at least one dosage of study medication. The primary analysis was a assessment of the rate of sustained virologic response at 24 weeks after treatment between previously untreated individuals who received three direct-acting antiviral agents with ribavirin for eight weeks and the ones who received the same therapy for 12 weeks .